Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Hughes

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNetMichele Baccarani, Jorge Cortes, Fabrizio Pane, et al.
Blood|August 8, 2008
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trialsSusan Branford, Linda Fletcher, Nicholas C P Cross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous LeukemiaSieghart Sopper, Satu Mustjoki, Deborah White, et al.
NPJ Dementia|June 22, 2026
Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer's disease and related dementiasNwanyieze Ngozi Jiakponnah, Joseph Curran, Tamlyn Watermeyer, et al.
The Journal of Biological Chemistry|February 11, 2005
The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolismAlexei Savchenko, Nevan Krogan, John R Cort, et al.
Research Square|February 6, 2026
Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer's disease and related dementiasNwanyieze Jiakponnah, Joseph Curran, Tamlyn Watermeyer, et al.
Social Psychiatry and Psychiatric Epidemiology|March 13, 2026
Midlife exposure to neighborhood greenness and later-life cognitive decline: The Multi-Ethnic Study of AtherosclerosisLilah M Besser, Lun-Ching Chang, Kelly R Evenson, et al.
The New Phytologist|May 26, 2025
At-RS31 orchestrates hierarchical cross-regulation of splicing factors and integrates alternative splicing with TOR-ABA pathwaysTino Köster, Peter Venhuizen, Martin Lewinski, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid LeukemiaNaranie Shanmuganathan, Carol Wadham, Daniel Thomson, et al.
International Journal of Hematology|May 19, 2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALLArinobu Tojo, Kensuke Usuki, Akio Urabe, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNetMichele Baccarani, Jorge Cortes, Fabrizio Pane, et al.
Blood|August 8, 2008
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trialsSusan Branford, Linda Fletcher, Nicholas C P Cross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2017
Reduced CD62L Expression on T Cells and Increased Soluble CD62L Levels Predict Molecular Response to Tyrosine Kinase Inhibitor Therapy in Early Chronic-Phase Chronic Myelogenous LeukemiaSieghart Sopper, Satu Mustjoki, Deborah White, et al.
NPJ Dementia|June 22, 2026
Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer's disease and related dementiasNwanyieze Ngozi Jiakponnah, Joseph Curran, Tamlyn Watermeyer, et al.
The Journal of Biological Chemistry|February 11, 2005
The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolismAlexei Savchenko, Nevan Krogan, John R Cort, et al.
Research Square|February 6, 2026
Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer's disease and related dementiasNwanyieze Jiakponnah, Joseph Curran, Tamlyn Watermeyer, et al.
Social Psychiatry and Psychiatric Epidemiology|March 13, 2026
Midlife exposure to neighborhood greenness and later-life cognitive decline: The Multi-Ethnic Study of AtherosclerosisLilah M Besser, Lun-Ching Chang, Kelly R Evenson, et al.
The New Phytologist|May 26, 2025
At-RS31 orchestrates hierarchical cross-regulation of splicing factors and integrates alternative splicing with TOR-ABA pathwaysTino Köster, Peter Venhuizen, Martin Lewinski, et al.
The Journal of Molecular Diagnostics : JMD|May 13, 2022
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid LeukemiaNaranie Shanmuganathan, Carol Wadham, Daniel Thomson, et al.
International Journal of Hematology|May 19, 2009
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALLArinobu Tojo, Kensuke Usuki, Akio Urabe, et al.
Pageof 15